Experiment 666158

Worktypes

PHARMACOLOGY OF COMPOUND - IN VITRO

Compounds isolated

NARINGENIN

Details

PropertyValue
Pharmacology
17-BETA-HYDROXYSTEROID OXIDOREDUCTASE INHIBITION
OrganismEmpty organism
CitationMAKELA,S: POUTANEN,M: KOSTIAN,ML: LEHTIMAKI,N: STRAUSS,L: SANTTI,R: VIHKO,R:. (1998). INHIBITION OF 17BETA-HYDROXYSTEROID OXIDOREDUCTASE BY FLAVONOIDS IN BREAST AND PROSTATE CANCER CELLS.. 217(3)
Amount utilized
Compound isolated
DiseaseVS.PURIFIED 17-BETA-HSOR TYPE I.
Dose amount1.2 MICROMOLS
Number48
Qualitative resultACTIVE
Dose expressionCONC USED